Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients.
Stereotactic ablative radiotherapy (SABR)
breast
elderly
oligometastatic
radiotherapy
Journal
Translational cancer research
ISSN: 2219-6803
Titre abrégé: Transl Cancer Res
Pays: China
ID NLM: 101585958
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
05
07
2019
accepted:
23
08
2019
entrez:
4
2
2022
pubmed:
1
1
2020
medline:
1
1
2020
Statut:
ppublish
Résumé
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
Identifiants
pubmed: 35117963
doi: 10.21037/tcr.2019.08.29
pii: tcr-09-S1-S197
pmc: PMC8797947
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
S197-S206Informations de copyright
2020 Translational Cancer Research. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.08.29). The series “Radiotherapy for Breast Cancer in Advanced Age” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1132-40
pubmed: 19345514
Psychooncology. 2013 May;22(5):1002-7
pubmed: 22565359
Cancer. 2004 Apr 15;100(8):1705-11
pubmed: 15073860
Radiother Oncol. 2018 Mar;126(3):547-557
pubmed: 29397209
Qual Life Res. 2000;9(4):369-75
pubmed: 11131929
Breast Cancer Res Treat. 2015 Feb;149(3):743-9
pubmed: 25638395
Breast Cancer Res Treat. 2009 Jun;115(3):601-8
pubmed: 18719992
Clin Lung Cancer. 2014 Mar;15(2):131-5
pubmed: 24157245
J Gastrointest Oncol. 2014 Jun;5(3):190-7
pubmed: 24982767
Rep Pract Oncol Radiother. 2019 Jan-Feb;24(1):86-91
pubmed: 30505238
Clin Transl Radiat Oncol. 2017 Dec 23;9:5-11
pubmed: 29594244
J Clin Oncol. 2002 Feb 1;20(3):620-3
pubmed: 11821439
Int J Mol Sci. 2019 May 02;20(9):
pubmed: 31052488
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):612-8
pubmed: 22436795
Acta Oncol. 2016 May;55(5):633-7
pubmed: 27046290
Radiother Oncol. 2015 Jan;114(1):109-16
pubmed: 25466369
Radiother Oncol. 2018 Jan;126(1):177-180
pubmed: 28943046
Acta Oncol. 2019 Jan;58(1):74-80
pubmed: 30280633
Breast Cancer Res Treat. 2018 Jan;167(2):579-590
pubmed: 29039120
Asia Pac J Clin Oncol. 2019 Mar;15 Suppl 2:14-19
pubmed: 30859749
J Clin Oncol. 2014 Aug 20;32(24):2595-603
pubmed: 25071125
Age Ageing. 1997 Mar;26(2):107-14
pubmed: 9177667
Rep Pract Oncol Radiother. 2013 Nov 01;18(6):387-96
pubmed: 24416584
J Am Geriatr Soc. 2005 Sep;53(9):1504-9
pubmed: 16137279
Radiol Med. 2018 Jun;123(6):406-414
pubmed: 29455424
J Gastrointest Oncol. 2016 Jun;7(3):479-86
pubmed: 27284482
J Clin Oncol. 1995 Jan;13(1):8-10
pubmed: 7799047
Expert Rev Neurother. 2016 Aug;16(8):903-14
pubmed: 27177183
Ann Oncol. 2014 Nov;25(11):2134-2146
pubmed: 24625455
Acta Oncol. 2012 May;51(5):596-602
pubmed: 22548366
J Neurooncol. 2012 Dec;110(3):381-8
pubmed: 23001361
J Clin Oncol. 2011 Apr 1;29(10):1290-6
pubmed: 21357782
Anticancer Res. 2018 Aug;38(8):4961-4968
pubmed: 30061276
Biomed Res Int. 2017;2017:1695101
pubmed: 29387715
Breast. 2016 Apr;26:11-7
pubmed: 27017237
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):518-25
pubmed: 25194669
Clin Geriatr Med. 2012 Feb;28(1):105-14
pubmed: 22326038
JAMA. 2010 Mar 17;303(11):1070-6
pubmed: 20233825
Br J Radiol. 2015 Sep;88(1053):20150111
pubmed: 26183933
J Oncol Pract. 2017 Mar;13(3):157-166
pubmed: 28282277
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):257-63
pubmed: 23570699
J Clin Oncol. 2013 Jan 1;31(1):65-72
pubmed: 23213105
Cancer. 2005 Nov 15;104(10):2244-54
pubmed: 16216003
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e479-86
pubmed: 22704705
Lancet. 2019 May 18;393(10185):2051-2058
pubmed: 30982687
Breast. 2018 Dec;42:150-156
pubmed: 30296648
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):336-42
pubmed: 23433800
Front Oncol. 2019 May 01;9:337
pubmed: 31119099
Aging Clin Exp Res. 2019 Jan;31(1):109-114
pubmed: 29594874
JAMA. 2004 Jun 9;291(22):2720-6
pubmed: 15187053
J Bone Miner Res. 2014 Mar;29(3):581-9
pubmed: 23959594
Cancer. 2007 Oct 15;110(8):1796-802
pubmed: 17786939
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Semin Radiat Oncol. 2006 Apr;16(2):67-76
pubmed: 16564442
J Geriatr Oncol. 2014 Jul;5(3):245-51
pubmed: 24703978
J Clin Oncol. 2007 Mar 10;25(8):947-52
pubmed: 17350943
Jpn J Clin Oncol. 1998 Jun;28(6):368-73
pubmed: 9730151
Ann Oncol. 2001;12 Suppl 3:S49-52
pubmed: 11804385
J Neurooncol. 2015 Oct;125(1):149-56
pubmed: 26307446
Spine (Phila Pa 1976). 1990 Jan;15(1):1-4
pubmed: 2326692
J Clin Oncol. 1996 Aug;14(8):2197-205
pubmed: 8708708
J Clin Oncol. 2009 Apr 1;27(10):1579-84
pubmed: 19255320
Eur J Cancer. 1996 Oct;32A(11):1876-87
pubmed: 8943669
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8
pubmed: 20638194
J Natl Cancer Inst. 2010 Apr 7;102(7):456-63
pubmed: 20220104
J Geriatr Oncol. 2017 Nov;8(6):421-427
pubmed: 28739158
Cancer. 2012 Mar 1;118(5):1457-65
pubmed: 21837676
Radiother Oncol. 2019 Feb;131:45-51
pubmed: 30773186
Breast Cancer Manag. 2015;4(1):53-64
pubmed: 25733982